“…Indeed, macrophages can account for up to 50% of the tumour mass in breast carcinoma (Kelly et al, 1988;O'Sullivan and Lewis, 1994;Leek et al, 1994). Macrophages are known to be involved in the angiogenic process, and can be stimulated in hypoxic, avascular regions of the tumour microenvironment to secrete a wide range of angiogenic factors, including vascular endothelial growth factor (VEGF), basic fibroblast factor (bFGF), tumour necrosis factor α (TNFα), endothelial growth factor (EGF), interferons, and others (Leek et al, 1997). Additionally, tumour hypoxia alone can also alter the effects of growth factors and cytokines, induce transcription factors and DNA repair enzymes, and has been associated with increased tumour aggressiveness (Brizel et al, 1996;Dachs and Stratford, 1996).…”